SMAD3 and chronic kidney disease: Taken together, all these data suggested that Smad3 and JNK signaling pathways may play an essential role in the pathogenesis of tubulointerstitial fibrosis and inflammation and that inhibition of Smad3 and JNK signaling may retard the development and progression of CKD.